Day: April 13, 2022

Nuvectis Pharma Recaps Poster Presentation Highlights for NXP900 at the 2022 American Association for Cancer Research (AACR) Conference

Written by Customer Service on April 13, 2022. Posted in Public Companies.

Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis” or the “Company”), a biopharmaceutical company focused on the development of precision medicines for serious conditions of unmet medical need in oncology, today provided highlights from the poster presentation of NXP900 that took place yesterday at the American Association for Cancer Research (“AACR”) Conference in New Orleans. “A growing body of scientific evidence provides exciting development opportunities for NXP900″ said Ron Bentsur, Chairman and Chief Executive Officer of Nuvectis. “NXP900 is a very potent and selective SRC/YES1 inhibitor with a unique mechanism of action that inhibits both the catalytic and scaffolding functions of the target kinases. Yesterday’s poster presentation demonstrated for the first time the potency...

Isracann Biosciences Acquires Natural Health Medicine Developer and Appoints Natural Health Products Officers

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, April 13, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) is pleased to announce that, further to the Company’s news releases dated February 23, 2022 and March 28, 2022, it has closed its acquisition of Praesidio Health Inc. (“Praesidio”). Pursuant to the definitive agreement dated March 24, 2022 with Praesidio and the shareholders of Praesidio (the “Praesidio Shareholders”), the Company acquired all of the issued and outstanding shares in the capital of Praesidio (the “Praesidio Shares”) for aggregate consideration of C$4,000,000 in common shares (the “Consideration Shares”) in the capital of the Company (the “Transaction”). Praesidio will operate as a wholly-owned subsidiary of the Company. Praesidio (https://www.praesidiohealth.com/) is an...

Emergia Inc. Announces Closing of a Private Placement of Convertible Debentures and Units

Written by Customer Service on April 13, 2022. Posted in Public Companies.

MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — (CSE: EMER) Emergia Inc. (the “Corporation or “Emergia”) is pleased to announce that it has completed a closing of a private placement for a total amount of $1,305,000 in cash, composed of $705,000 of convertible debentures (the “Debentures”) and $600,000 in units (the “Units”) of the Corporation at a price of $0.80 per Unit. The Debentures bear interest at the rate of 8% per year, accruing in arrears, payable semi-annually in cash or in Class A Common Shares (the “Shares”) of the Corporation. The Debentures are convertible at the holder’s option into one unit (the “Debentures Units”) of the Corporation at a conversion price of $0.90. Each Debenture Unit is composed of one Share in the capital of the Corporation and two (2) warrants of the Corporation: (i) a warrant of the Corporation...

EV Technology Group Commences Construction on Moke Flagship – Set to Open in Summer 2022

Written by Customer Service on April 13, 2022. Posted in Public Companies.

Casa Moke – 3D views (non-final) Casa Moke – 3D views (non-final)Casa Moke – 3D views (non-final) Casa Moke – 3D views (non-final)ST TROPEZ, France, April 13, 2022 (GLOBE NEWSWIRE) — EV Technology Group Ltd.’s wholly owned subsidiary, Moke France SAS, announces today that it has commenced construction on a Moke flagship store in St Tropez, France. The construction of this flagship fits with EV Technology Group’s strategy of electrifying iconic brands: carefully selecting legendary cars and bringing them forward with an electric twist. Moke, the heritage car created by Austin Mini’s designer, Sir Alec Issogonis, began its rise to cult status in the 1960’s when the likes of Brigitte Bardot and Alain Delon drove it along the French Riviera coastline. “Saint-Tropez has a strong resonance in the worldwide...

Texas City Joins Growing List of Municipalities Securing Access to Sensitive Data with BIO-key’s PortalGuard Identity and Access Management Platform

Written by Customer Service on April 13, 2022. Posted in Public Companies.

DALLAS and WALL, N.J., April 13, 2022 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that a Texas city has selected its PortalGuard IAM platform, with support for a broad array of multi-factor authentication (MFA) options, to protect its enterprise applications and data. Leveraging the PortalGuard IAM platform, the municipality can strengthen its overall security posture and effectively respond to evolving cyber threats. This new customer relationship, BIO-key’s first with a Texas municipality, was secured by Dallas-based IT consulting firm Mejeticks through BIO-key’s master agent Intelisys. Cyber-attacks against municipalities have increased significantly in...

Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring

Written by Customer Service on April 13, 2022. Posted in Public Companies.

Additional data covered a variety of specialties, including vascular surgery, plastic surgery, general surgery, and podiatry, to further support clinical efficacy of AC5® Advanced Wound System in acute, chronic, and challenging wounds. FRAMINGHAM, Mass., April 13, 2022 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical devices, today announced that two clinical case reports on the use of AC5® Advanced Wound System (“AC5”) were presented as Poster Presentations and three additional cases were presented during a live Open Air Studio session at the 2022 Symposium on Advanced Wound Care (SAWC) Spring. The Open Air Studio video, featuring Terry Treadwell, MD, FACS, and Brock Liden, DPM, will be shared as it becomes available...

With 8.2% CAGR, US Sleep Disorder Clinics Market Size worth USD 15.92 Billion in 2028

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

The US sleep disorder clinics market size was USD 8.62 billion in 2020. The market is projected to grow from USD 9.20 billion in 2021 to USD 15.92 billion in 2028 at a CAGR of 8.2% during the 2021-2028 period. Pune, India, April 13, 2022 (GLOBE NEWSWIRE) — The US sleep disorder clinics market size was USD 8.62 billion in 2020. The market is projected to grow from USD 9.20 billion in 2021 to USD 15.92 billion in 2028 at a CAGR of 8.2% during the 2021-2028 period. This vital information is presented by Fortune Business Insights™, in its report, titled, “US Sleep Disorder Clinics Market, 2021-2028.” Factors such as rising incidences of heart diseases & nerve disorders and increasing awareness among the general population will increase the footprint of the market during the forecast period. Additionally, the rising shift of patients...

With 16.1% CAGR, Viral Clearance Market Size worth USD 1519.7 Billion in 2029

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

The global viral clearance market size was USD 492.9 million in 2021. The market in 2022 was valued at USD 535.6 million and is expected to reach USD 1,519.7 million by 2029, exhibiting a CAGR of 16.1% during the forecast period. Pune, India, April 13, 2022 (GLOBE NEWSWIRE) — The global viral clearance market size was USD 492.9 million in 2021. The market in 2022 was valued at USD 535.6 million and is expected to reach USD 1,519.7 million by 2029, exhibiting a CAGR of 16.1% during the forecast period. Robust investments in biotechnology, pharmaceutical products, rising research and development activities, and increasing healthcare expenditures may fuel industry progress. Fortune Business Insights™ presents this information in its report titled “Viral Clearance Market, 2022-2029.” Viral clearance is crucial in manufacturing biosimilar,...

With 25.3% CAGR, Cyber Insurance Market Size Worth USD 36.85 Billion in 2028

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

Leading companies in the global cyber insurance market are American International Group Inc., Munich Re Group, Zurich Insurance Co. Ltd, Berkshire Hathaway, XL Group Ltd, The Chubb Corporation, Aon Plc., Axis Capital, Lockton Companies Inc., Hiscox Inc. Pune, India, April 13, 2022 (GLOBE NEWSWIRE) — The global cyber insurance market size is projected to grow from USD 7.60 billion in 2021 to USD 36.85 billion in 2028 at a CAGR of 25.3% in the 2021-2028 period. The global market size was USD 6.15 billion in 2020. This information is provided by Fortune Business Insights, in its report, titled, “Cyber Insurance Market, 2021-2028.” According to our researchers, the surging cybersecurity threat and data breaches is steering businesses to deploy insurance policies. Similarly, several nations are inflicting penalties and supervisory guidelines...

With 7.4% CAGR, Dental Market Size worth USD 63.93 Billion in 2029

Written by Customer Service on April 13, 2022. Posted in Mergers And Acquisitions.

Dental Market Covered By Key Companies – 3M, Institut Straumann AG, Henry Schein, Inc., Angelalign Technology Inc., SHOFU INC. , PLANMECA OY, J. MORITA CORP, Dentsply Sirona, Align Technology, Inc., Zimmer Biomet, Coltene, Ultradent Products Inc., Septodont, A.B. Dental Pune, India, April 13, 2022 (GLOBE NEWSWIRE) — The global dental market size was valued at USD 36.32 billion in 2021. The market is expected to grow from USD 38.84 billion in 2022 to USD 63.93 billion by 2029, exhibiting a CAGR of 7.4% during the forecast period. Rising awareness regarding periodontics and endodontics treatment and increasing invisible orthodontics trends is expected to fuel market growth. Fortune Business Insights™ presents this information in its report titled “Dental Market, 2022-2029.” This market encompasses equipment and consumables...

Day: April 13, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice